VARIABLE INTEREST ENTITY

12 Months Ended

Dec. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

VARIABLE INTEREST ENTITY

NOTE 3 — VARIABLE INTEREST ENTITY

A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity’s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.

The Company followed ASC Topic 810, “Consolidation”, utilizing a qualitative approach, and determined that it is the primary beneficiary of its VIE, Aikawa Medical Management, Inc. (“AMM”) and consolidated the result of operations, financial conditions, and cash flows of AMM in the consolidated financial statements.

The following amounts and balances of AMM were included in the Company’s consolidated financial statements of December 31, 2024 and 2023 and for the years then ended:

	As of December 31,
	2024		2023
ASSETS
Current assets
Cash and cash equivalents	$	41,247	$	28,934
Accounts receivable		20,076		26,916
Prepaid expenses and other current assets		32,493		11,074
Total Current Assets		93,816		66,924
Property and equipment, net		1,799,372		1,799,372
Loans receivable from subsidiaries of the Company		3,122,157		3,060,581
Other assets		2,275		2,275
Total Non-Current Assets		4,923,804		4,862,228
Total Assets	$	5,017,620	$	4,929,152
LIABILITIES
Current Liabilities
Accounts payable	$	18,904	$	17,942
Accrued liabilities and other current liabilities		17,824		17,824
Due to related party		2,797,018		2,875,408
Total Current Liabilities		2,833,746		2,911,174
Loan payable to a subsidiary of the Company		8,245,328		9,157,660
Total Non-current Liabilities		8,245,328		9,157,660
Total Liabilities	$	11,079,074	$	12,068,834

SBC MEDICAL GROUP HOLDINGS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3 — VARIABLE INTEREST ENTITY (cont.)

	For the Years Ended December 31,
	2024			2023
Revenues	$	269,800		$	163,146
Cost of revenues	$	56,510		$	61,647
Total operating expenses	$	402,397		$	128,549
Net loss	$	(47,782	)	$	(27,050	)
Net cash provided by (used in) operating activities	$	(182,991	)	$	202,624
Net cash provided by (used in) investing activities	$	195,000		$	(90,000	)
Net cash used in financing activities	$	(78,390	)	$	(158,714	)